Where does Protiva Biotherapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Protiva Biotherapeutics, Inc. ranks #13,634 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Protiva Biotherapeutics, Inc. hold?

Protiva Biotherapeutics, Inc. holds 22 US utility patents granted between 2015 and 2018, spanning 13 technology areas.

What is Protiva Biotherapeutics, Inc.'s Innovation Score?

Protiva Biotherapeutics, Inc. has an Innovation Score of 37.9 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Protiva Biotherapeutics, Inc. focus on?

Protiva Biotherapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 22 patents, ranking #1,019 of 7,163 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Protiva Biotherapeutics, Inc.'s patent grant rate increasing or decreasing?

Protiva Biotherapeutics, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Protiva Biotherapeutics, Inc.'s patents?

Protiva Biotherapeutics, Inc.'s patents average 23.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Protiva Biotherapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Protiva Biotherapeutics, Inc.

USPTO PatentsView assignee record - 22 granted patents across 13 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Protiva ranks #13,634 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 13 technology areas.

#13,634
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.9/100): 23.8
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13634 · Foreign Corporation #13,634 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,634/49,997
PHOTO-FINISH Pramana
CPC-FOCUS A61K · 13 areas
INNOV-THIN 37.9/100
CLAIMS-DENSE 23.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pramana, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Protiva’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (29%) Velocity 0.0 pts (0%) Breadth 12.7 pts (34%) Claim depth 14.3 pts (38%)

Qualcomm Incorporated · highest

85
Protiva Biotherapeut… · this assignee

38
3D Lighting… · lowest

7

What this shows Protiva's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Protiva?

Each dot is one of Protiva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Protiva’s own 23.8 claims/patent is ABOVE the 16.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Protiva vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Protiva's grants concentrate

Protiva Biotherapeutics, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (12 grants) versus a trough of 1 in 2017. By volume, Protiva sits between Pramana, Inc. and Q.E.D. Environmental Systems, Inc..

Pramana

22
Primera Technology

22
Pro-cord S p A

22
Products Unlimited

22
Prove Identity

22
Provincial Health…

22
Provivi

22
Q E D Environment…

22
Protiva Biotherap… ◀

22

What this shows Protiva holds 22 patents at rank #13,632, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Protiva

By rank, the assignees closest to #13,632 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Protiva's primary technology class.

Protiva's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Protiva Biotherapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	54.5%
2016	7	31.8%
2017	1	4.5%
2018	2	9.1%

Which technologies does Protiva Biotherapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 17

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

C07C - Acyclic OR Carbocyclic Compounds 3

Y10T - Technical Subjects Covered BY Former US Classification 2

C12Y - Enzymes 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

C07D - Heterocyclic Compounds 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C08L - Compositions OF Macromolecular Compounds 1

C07J - Steroids 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Protiva Biotherapeutics, Inc.'s patent record in context - here's where to go next.

Protiva Biotherapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #13,634 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Protiva Biotherapeutics, Inc. against Pramana, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.